SKI Market

A+| A| A-|

Indian Indices

Sensex

76,810.62 546.29
( 0.72%)

Global Indices

Nasdaq

51,705.57 482.31
(0.94%)

Dow Jones

7,575.20 122.74
(1.65%)

Hang Seng

69,393.70 76.20
(0.11%)

Nikkei 225

10,435.69 -36.03
(-0.34%)

Forex

USD-INR

94.92 -0.57
(-0.60%)

EUR-INR

109.83 -0.42
(-0.38%)

GBP-INR

127.25 -0.49
(-0.38%)

JPY-INR

0.59 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Haleos Labs Limited

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540679

INE320X01016

709.7350897

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HALEOSLABS

24.2

430.24

EPS(TTM)

Face Value()

Div & Yield %

58.8

0.11

Back

Kwality Pharmaceuticals receives upgrade in credit ratings from ICRA

May 08,2026

Kwality Pharmaceuticals has received upgrade in credit ratings for bank loan facilities of the company at ICRA BBB+; Stable / ICRA A2. Further, the ratings have been removed from the “Issuer Not Cooperating” category.

76,810.62 546.29 ( 0.72%)

51,705.57 482.31 (0.94%)

7,575.20 122.74 (1.65%)

69,393.70 76.20 (0.11%)

10,435.69 -36.03 (-0.34%)

94.92 -0.57 (-0.60%)

109.83 -0.42 (-0.38%)

127.25 -0.49 (-0.38%)

0.59 0.00 (-0.48%)